Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanofi H1N1 Vaccine +/- AS03 Adjuvant in Adults and Elderly
NCT00963157Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2009
- Primary completion
- Dec 2010
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza A (H1N1) vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2009; status: completed.
02
Drugs
Influenza A (H1N1) vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00963157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00963157.